Which therapy helps kids with MIS-C recover fastest? new study has answers.
NCT ID NCT04898231
First seen Nov 04, 2025 · Last updated May 22, 2026 · Updated 43 times
Summary
This study looked at 73 children with MIS-C, a rare but serious inflammatory condition that can appear weeks after a COVID-19 infection. Researchers compared three treatments (infliximab, anakinra, and steroids) to see which one helped children recover fastest without needing more medicine. The goal was to find the best initial therapy to reduce inflammation and prevent complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTISYSTEM INFLAMMATORY SYNDROME-CHILDREN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital Michigan
Detroit, Michigan, 48201, United States
-
Rady Children's Hospital
San Diego, California, 92123, United States
Conditions
Explore the condition pages connected to this study.